Patients Who Receive Androgen Deprivation Therapy Risk Adverse Cognitive Changes

Affiliations

¹ University of Queensland Centre for Clinical Research and Royal Brisbane and Women's Hospital, Brisbane, Queensland; and Edith Cowan University, Joondalup, Western Australia, Australia f.gardiner@uq.edu.au.
² Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
³ University of Queensland, Brisbane, Queensland, Australia.
⁴ Griffith University, Brisbane, Queensland, Australia.
⁵ Queen Elizabeth II Hospital, Brisbane, Queensland, Australia.
⁶ Mater Hospitals, Brisbane, Queensland, Australia.
⁷ Royal Marsden Hospital, London, United Kingdom.

Comment

Robert A Gardiner et al. J Clin Oncol. 2015.

. 2015 Dec 20;33(36):4314-5.

doi: 10.1200/JCO.2015.63.5698. Epub 2015 Oct 26.

¹ University of Queensland Centre for Clinical Research and Royal Brisbane and Women's Hospital, Brisbane, Queensland; and Edith Cowan University, Joondalup, Western Australia, Australia f.gardiner@uq.edu.au.
² Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
³ University of Queensland, Brisbane, Queensland, Australia.
⁴ Griffith University, Brisbane, Queensland, Australia.
⁵ Queen Elizabeth II Hospital, Brisbane, Queensland, Australia.
⁶ Mater Hospitals, Brisbane, Queensland, Australia.
⁷ Royal Marsden Hospital, London, United Kingdom.

No abstract available

Comment on

Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled Comparison.
Gonzalez BD, Jim HS, Booth-Jones M, Small BJ, Sutton SK, Lin HY, Park JY, Spiess PE, Fishman MN, Jacobsen PB. Gonzalez BD, et al. J Clin Oncol. 2015 Jun 20;33(18):2021-7. doi: 10.1200/JCO.2014.60.1963. Epub 2015 May 11. J Clin Oncol. 2015. PMID: 25964245 Free PMC article.